The rise of vibe coding can further amplify these problems as more operational context, architectural decisions, and business knowledge become scattered across prompts, conversations, generated code, ...

OAKLAND, Calif., June 01, 2026--(BUSINESS WIRE)--Fivetran, the data foundation for AI, today announced the completion of its merger with dbt Labs, the creator of dbt and the leader in standards for AI ...

Combined company serves more than 100,000 data teams globally and launches its first joint product innovations for the agentic era Together, Fivetran + dbt Labs support a global community of more than ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

DBT is an evidenced based approach to reduce symptoms of mood, anxiety, eating, addiction, and personality disorders. DBT groups provide skills training in: Mindful Awareness, Mood Regulation, ...

A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law in an approachable way. Her ...

Therapists who specialize in teaching DBT skills focus on four modules of skills that help people cope with emotional distress in adaptive and productive ways. In particular, there are 4 foundational ...

When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...

From December 2022 to February 2024, a total of 36 patients with biopsy-confirmed HR+/HER2− breast cancer who provided informed consent to participate were screened for eligibility. Five patients were ...

All articles published in Scientific Data are made freely and permanently available online immediately upon publication, without subscription charges or registration barriers. Further information ...

Praxis Precision Medicines (NASDAQ:PRAX) added ~18% in the premarket on Monday after the Boston-area biotech announced topline results from a mid-stage trial for vormatrigine, its experimental therapy ...